Literature DB >> 20648658

Appearance of phagocytic microglia adjacent to motoneurons in spinal cord tissue from a presymptomatic transgenic rat model of amyotrophic lateral sclerosis.

Tomomi Sanagi1, Shigeki Yuasa, Yasuko Nakamura, Eri Suzuki, Masashi Aoki, Hitoshi Warita, Yasuto Itoyama, Shigeo Uchino, Shinichi Kohsaka, Keiko Ohsawa.   

Abstract

Microglial activation occurs early during the pathogenesis of amyotrophic lateral sclerosis (ALS). Recent evidence indicates that the expression of mutant Cu(2+)/Zn(2+) superoxide dismutase 1 (SOD1) in microglia contributes to the late disease progression of ALS. However, the mechanism by which microglia influence the neurodegenerative process and disease progression in ALS remains unclear. In this study, we revealed that activated microglia aggregated in the lumbar spinal cord of presymptomatic mutant SOD1(H46R) transgenic rats, an animal model of familial ALS. The aggregated microglia expressed a marker of proliferating cell, Ki67, and phagocytic marker proteins ED1 and major histocompatibility complex (MHC) class II. The motoneurons near the microglial aggregates showed weak choline acetyltransferase (ChAT) immunoreactivity and contained reduced granular endoplasmic reticulum and altered nucleus electron microscopically. Furthermore, immunopositive signals for tumor necrosis factor-alpha (TNFalpha) and monocyte chemoattractant protein-1 (MCP-1) were localized in the aggregated microglia. These results suggest that the activated and aggregated microglia represent phagocytic features in response to early changes in motoneurons and possibly play an important role in ALS disease progression during the presymptomatic stage.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20648658     DOI: 10.1002/jnr.22424

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  28 in total

1.  Regulation of postnatal forebrain amoeboid microglial cell proliferation and development by the transcription factor Runx1.

Authors:  Morena Zusso; Laurent Methot; Rita Lo; Andrew D Greenhalgh; Samuel David; Stefano Stifani
Journal:  J Neurosci       Date:  2012-08-15       Impact factor: 6.167

Review 2.  Let's make microglia great again in neurodegenerative disorders.

Authors:  Marie-Victoire Guillot-Sestier; Terrence Town
Journal:  J Neural Transm (Vienna)       Date:  2017-10-12       Impact factor: 3.575

Review 3.  CD4 + T Cells and Neuroprotection: Relevance to Motoneuron Injury and Disease.

Authors:  Kathryn J Jones; Amy E Lovett-Racke; Chandler L Walker; Virginia M Sanders
Journal:  J Neuroimmune Pharmacol       Date:  2015-07-07       Impact factor: 4.147

4.  Differential gene expression in the axotomized facial motor nucleus of presymptomatic SOD1 mice.

Authors:  Nichole A Mesnard; Virginia M Sanders; Kathryn J Jones
Journal:  J Comp Neurol       Date:  2011-12-01       Impact factor: 3.215

5.  Sigma-1R agonist improves motor function and motoneuron survival in ALS mice.

Authors:  Renzo Mancuso; Sara Oliván; Amaya Rando; Caty Casas; Rosario Osta; Xavier Navarro
Journal:  Neurotherapeutics       Date:  2012-10       Impact factor: 7.620

Review 6.  Differential contribution of microglia and monocytes in neurodegenerative diseases.

Authors:  Caroline Baufeld; Elaine O'Loughlin; Narghes Calcagno; Charlotte Madore; Oleg Butovsky
Journal:  J Neural Transm (Vienna)       Date:  2017-10-23       Impact factor: 3.575

7.  DOCK8 is expressed in microglia, and it regulates microglial activity during neurodegeneration in murine disease models.

Authors:  Kazuhiko Namekata; Xiaoli Guo; Atsuko Kimura; Nobutaka Arai; Chikako Harada; Takayuki Harada
Journal:  J Biol Chem       Date:  2019-07-23       Impact factor: 5.157

8.  Spinal but not cortical microglia acquire an atypical phenotype with high VEGF, galectin-3 and osteopontin, and blunted inflammatory responses in ALS rats.

Authors:  Maria Nikodemova; Alissa L Small; Stephanie M C Smith; Gordon S Mitchell; Jyoti J Watters
Journal:  Neurobiol Dis       Date:  2013-11-19       Impact factor: 5.996

9.  SOD1(G93A) transgenic mouse CD4(+) T cells mediate neuroprotection after facial nerve axotomy when removed from a suppressive peripheral microenvironment.

Authors:  Nichole A Mesnard-Hoaglin; Junping Xin; Melissa M Haulcomb; Richard J Batka; Virginia M Sanders; Kathryn J Jones
Journal:  Brain Behav Immun       Date:  2014-06-06       Impact factor: 7.217

10.  Interleukin-13 Gene Modification Enhances Grafted Mesenchymal Stem Cells Survival After Subretinal Transplantation.

Authors:  Libin Huang; Junmei You; Yao Yao; Maosong Xie
Journal:  Cell Mol Neurobiol       Date:  2019-12-02       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.